No Data
No Data
Lilly, Gilead, Amgen Started at Outperform by Bernstein
AbbVie Hits 9-week Low
Allergan Aesthetics to Present New Data at 2024 American Society for Dermatologic Surgery (ASDS) to Showcase Depth Across Facial Aesthetics and Insight Into Patient Perception
Wells Fargo Maintains AbbVie(ABBV.US) With Buy Rating, Maintains Target Price $205
Lupin Launches First Generic of Pred Forte(r) in US
Looking Into AbbVie's Recent Short Interest
loading...
No Data
No Data